Search Results

The latest from our world of transformation

VALK

  • Posted by Metavallon VC Team
  • On December 17, 2020
  • No tags found
End-to-end digital transaction solution for private markets.
Read More

OUR INVESTMENT IN [i2.d] TECHNOLOGIES – THE TECHNOLOGY ENABLER FOR THE SAAS

  • Posted by Metavallon VC Team
  • On December 16, 2020
  • No tags found
We are delighted to announce our latest Seed investment into [i2.d] technologies, an ICT technology firm offering cutting-edge technology for SaaS, to software vendors and service providers. Founded in 2018 by Ioannis P. Dimitriadis, [i2.d] technologies is targeting the SaaS market as a technology enabler with a unique product portfolio consisting of two initial products: […]
Read More

A B2B Startup’s Guide to Content Marketing

  • Posted by Marilena Kakkou
  • On December 7, 2020
  • No tags found
What is Content Marketing? Content marketing refers to online content such as blogs, press releases, social media posts, newsletters, opt-in email marketing campaigns, videos, and images that are posted online with the purpose of connecting and engaging with your target audience. It is thoughtful and relevant information that adds value—and in turn, increases your company’s […]
Read More

A Seed Startup’s guide to Investor Updates

  • Posted by Marilena Kakkou
  • On November 9, 2020
  • No tags found
You’ve landed the first funding for your startup, now you’ve got to make the most of it. An important part of this is putting together a regular, powerful investor update that will keep your stakeholders informed and allow them a glimpse of your startup through the CEOs lenses. Although this looks like another commitment, great […]
Read More

OUR INVESTMENT IN BIOPIX-T – THE STARTUP COMPANY BEHIND IRIS – THE NOVEL PORTABLE MOLECULAR DIAGNOSTIC DEVICE FOR POINT OF CARE

  • Posted by Metavallon VC Team
  • On September 9, 2020
  • No tags found
We are delighted to announce our latest Seed investment into biotech company BIOPIX-T, the startup company behind IRIS – the novel portable molecular diagnostic device for Point-of-Care. The investment round is joined by strategic angel investors from the healthcare and diagnostics sector. Founded in 2019 by George Papadakis, Electra Gizeli, Alexandros Pantazis, Nikolaos Fikas and […]
Read More

BIOPIX-T

  • Posted by Metavallon VC Team
  • On September 9, 2020
  • No tags found
Design and manufacturing of point-of-care molecular diagnostic devices.
Read More

5 B2B SaaS Growth Hacks by VC-backed Founders

  • Posted by Katerina Kanteraki
  • On September 4, 2020
  • No tags found
At Metavallon VC we work with world-class founders building B2B SaaS companies such as Useberry, Citizen, Mist.io, and Covve (for a full list of our investments and exits, please click here). In today’s blog, we’re going to take a deep dive into the most prominent, tried-and-true growth strategies employed by our B2B SaaS companies. Suppose […]
Read More

LANGaware

  • Posted by Metavallon VC Team
  • On July 22, 2020
  • No tags found
The machine learning and language biomarkers solution for neurodegenerative pathologies detection
Read More

OUR INVESTMENT IN LANGAWARE – THE MACHINE LEARNING AND LANGUAGE BIOMARKERS SOLUTION FOR NEURODEGENERATIVE PATHOLOGIES DETECTION

  • Posted by Metavallon VC Team
  • On July 22, 2020
  • No tags found
We are excited to announce our latest Seed investment into healthtech startup LangAware, which provides a solution of early cognitive assessment to prevent Alzheimer’s and related Dementias. Founded by Vassiliki Rentoumi, associate researcher in the field of Natural Language Processing and Computational Linguistics at SKEL of NCSR “Demokritos”, LangAware employs Artificial Intelligence to predict neurodegenerative […]
Read More